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Abstract: Leukocytes express both urokinase-
type plasminogen activator (uPA) and the uroki-
nase receptor (uPAR, CD87). We have shown that
neutrophil recruitment to the lung during P.
aeruginosa pneumonia is impaired in uPAR-defi-
cient (uPAR/) mice but is normal in uPA/
mice. However, both uPA/ mice and uPAR/
mice have impaired lung clearance of P. aerugi-
nosa compared with wild-type (WT) mice. To de-
termine the role of uPA and uPAR in antibacterial
host defense, we compared neutrophil bacterial-
phagocytosis, respiratory burst, and degranulation
among uPA/, uPAR/, and WT mice. Neu-
trophil phagocytosis was significantly diminished
comparing uPA/ and uPAR/ mice with WT
mice at all time points. The generation of superox-
ide by both uPA/ and uPAR/ neutrophils
was about half of that seen in WT neutrophils.
Degranulation of azurophilic granules was signifi-
cantly diminished in uPA/ neutrophils com-
pared with either uPAR/ or WT neutrophils. By
contrast, agonist-stimulated release of specific
granules was not diminished in either uPA/ or
uPAR/ mice compared with WT. We conclude
that the uPA/uPAR system modulates several of the
crucial steps in neutrophil activation that result in
bacterial killing and effective innate host defense.
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INTRODUCTION
To participate in innate immunity, neutrophils must accom-
plish several critical functions. First, during recruitment to an
infectious site, the cells must sense and become oriented to a
chemotactic gradient and then move through a complex se-
quence of adhesion, cytoskeletal rearrangement, movement,
and detachment steps [1, 2]. Neutrophils then must egress from
the vascular compartment and traverse tissue planes; a process
that might require extracellular proteases [3–5]. Finally, in
order to effect bacterial killing, the neutrophil must engulf the
invading pathogen, produce reactive oxygen intermediates—
particularly superoxide (O2–) via the activity of NADPH oxi-
dase—and release proteolytic and bactericidal proteins from
cytoplasmic granules.
Neutrophils express urokinase-type plasminogen activa-
tor (uPA) and high-affinity receptors for uPA (uPAR, CD87)
on the plasma membrane. This action enables them to
convert the proenzyme plasminogen to active plasmin and
concentrate it in the immediate pericellular environment
during cellular migration [6 – 8]. Plasmin is a protease of
broad specificity that can either directly or indirectly,
through the activation of latent metalloproteinases, degrade
extracellular matrix proteins and basement membranes [6,
9, 10]. In addition to providing a plasma membrane docking
site for uPA, uPAR, which is a glycosylphosphatidylinosi-
tol-anchored receptor, can couple with several other recep-
tors on the cell surface, most notably in neutrophils, the 2
integrin CD11b/CD18. We have demonstrated previously
that uPAR, by partnering with CD11b/CD18, facilitates the
integrin's adhesive and chemotactic functions [11–13]. In
addition to these in vitro function, we have also demon-
strated is the crucial role that uPAR plays in CD11b/CD18-
dependent neutrophil recruitment to the lung during P.
aeruginosa pneumonia in vivo. Mice deficient in uPAR
(uPAR/) had markedly decreased neutrophil recruit-
ment to the lung and had significantly impaired intra pul-
monary killing of the pathogen. By contrast, in the same P.
aeruginosa pneumonia model, mice deficient in uPA
(uPA/) recruited neutrophils indistinguishably from
wild-type (WT) mice. However, despite the abundant num-
bers of neutrophils present in the lungs of uPA/ mice
infected with P. aeruginosa, bacterial killing was impaired
[14]. This finding suggests that neutrophils do not activate
normal bactericidal mechanisms in the absence of uPA,
despite normal recruitment to the site of infection.
In the current study we sought to determine whether uPA
and/or uPAR are required for antibacterial neutrophil activa-
tion. We purified neutrophils from WT, uPA/, and
uPAR/ mice and assessed bacterial phagocytosis, super-
oxide generation, and degranulation responses.
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METHODS
Animals
Mice were housed in specific pathogen-free isolation rooms in the University
of Michigan Department of Laboratory Animal Medicine, which is fully ac-
credited by the American Association for Accreditation of Laboratory Animal
Care. All procedures were approved by the animal care committees of the
Veterans Administration and the University of Michigan Committee on Use
and Care of Animals (UCUCA).
Transgenic uPAR deficient mice (uPAR/), uPA-deficient mice
(uPA/), and background-matched control mice (WT) were generous
gifts from Peter Carmeliet. These mice were developed as described
previously [15, 16]. Genotype of the uPA, uPAR/, and WT mice was
confirmed by PCR or RT-PCR analysis as described previously [16, 17].
Mice of this background (C57B6/129) are immunocompetent [18, 19].
Antibodies and materials
FITC-conjugated anti-murine CD11b (M1/70.15) mAbs and rat IgG (control)
were from PharMingen (San Francisco, CA). Active Mouse Urokinase (MUPA-
903) was obtained through Molecular Innovations, Inc. (Southfield, MI).
Quantification of phagocytosis
Mice were injected i.p. with 0.1 ml heparin (1000 units/ml). After 2 min, the
mice were humanely killed and bled from the abdominal aorta into tubes
containing 0.1 ml of 25 units/ml heparin. Blood was immediately placed on ice.
Then, 50 l was aliquoted into 12  75 mm polypropylene tubes containing
50 l phosphate buffered saline (PBS) BODIPY FL- E. Coli (Molecular Probes,
Eugene, OR), sonicated in a Branson Ultrasonic Cleaner (Danbury, CT) in
three 20 s bursts, and placed on ice. After which, 0.1 l was aliquoted into
each tube containing whole blood. Samples were either kept on ice as negative
controls or warmed to 37°C and gently shaken (Lab-Line Microprocessor Orbit
Shaker Water Bath at 70 rpm, Lab-Line Instruments, Inc., Melrose Park, IL).
At the indicated time points, samples were removed, phagocytosis was halted
by rapid chilling on ice, and extracellular fluorescence was quenched by using
0.25 mg/ml Trypan Blue (Sigma Chemical Co., St. Louis, MO). Immediately, 2
mls of ice-cold PBS was added, and samples were centrifuged 5 min at 400
rpm. The samples were then washed, and the RBC was lysed by using a Whole
Blood Lysing Reagent Kit (Coulter Corporation, Miami, FL). Samples were
then washed twice and resuspended in 300 l PBS. Cells were then either
centrifuged onto glass slides and stained with hematoxylin and eosin for
fluorescent photomicroscopy or were stained with 0.5 g/ml propidium iodide
(to exclude dead cells) and fluorescence intensity determined on a Beckman
Coulter Elite ESP Flow Cytometer (Coulter Corporation). Effectiveness of
quenching was documented by the absence of fluorescence in negative control
cells. Separate samples were stained with R-PE conjugated Ly-6G (GR-1,
PharMingen) and used to set the neutrophil gate.
Generation of recombinant murine uPA for
repletion of uPA/ PMN during phagocytosis
uPA binding to uPAR is species-specific. We generated murine uPA by
adenovirus-mediated murine uPA transfection in vitro, as described previously
with minor modifications [20]. Briefly, human lung epithelial cells (A549) were
cultured in Dulbecco’s modified Eagle’s medium supplemented with 10% FBS.
Confluent cells were split into six-well plates at a 1:5 dilution 24 h prior to
infection. At 18 h, the media were changed, and at 24 h 108 virus particles
containing either the murine uPA cDNA construct or an empty cassette were
added to each well. After 4 h at 37°C, the supernatants were aspirated, the
cells were washed, fresh media were added, and the cells were incubated at
37°C. Conditioned media were collected 24 h later and analyzed for uPA
activity, as described previously [20]. Conditioned media of cells infected with
adenovirus-murine uPA (murine uPA media) had 4.5 plough units/ml of uPA
activity, whereas conditioned media of cells infected with the control adeno-
virus (control media) had no detectable uPA. Phagocytosis was quantified as
above, except that the collected blood (50 l) was aliquoted into 12  75 mm
polypropylene tubes containing 50 l of murine uPA media, or control media,
and was incubated for 60 min at room temperature prior to the addition of
BODIPY FL-E. Coli (Molecular Probes).
Isolation of murine peritoneal neutrophils
Neutrophils were elicited by two i.p. injections of 9% casein (1 ml, Sigma) 18 h
apart. Three hours later, the mice were humanely killed. The peritoneal cells
were harvested into PBS  0.02% EDTA, washed and layered onto a three-
step Percoll (Amersham Pharmacia, Piscataway, NJ) gradient (1.07, 1.06, 1.05
g/ml), and centrifuged at 400 rpm for 45 min at 4°C; the neutrophil band was
removed. Neutrophil purity was confirmed by Tissue-Tek II staining (Richard-
Allan Scientific, Kalamzoo, MI) and visual inspection. Cells were adjusted to
6  105/ml in HBSS (Invitrogen, Carlsbad, CA).
Determination of superoxide production
Neutrophils were purified as above, and RBCs lysed by using a Whole Blood
Lysing Reagent Kit (Coulter Corporation). Cells were adjusted to 5  106/ml
in PBS/0.9 mM Ca/0.5 mM Mg /7.5 mM glucose. Cytochrome C (Type VI,
Sigma) was dissolved in PBS/1.5 mM glucose. Superoxide dismutase (Sigma)
was dissolved in endotoxin-free water at 3 mg/ml. Samples were assayed in the
presence and absence of superoxide dismutate. PBS/glucose (176 l ), cyto-
chrome c (12.5 l), SOD or water (10 l), and cells mixture (50 l) was placed
into a 96-well, flat-bottom plate (Costar 3596). For experiments using fMLP,
Cytochalasin B (Sigma) was added at 2 g/ml. Wells were mixed and incu-
bated at 37°C in a Spectramax 190 Microplate Spectrophotometer (Molecular
Devices, Sunnyvale, CA) for 3 min. fMLP (Calbiochem, La Jolla, CA) or
phorbol 12-myristate 13-acetate (PMA; Sigma) in the indicated concentration
was quickly added, and the assay was monitored kinetically for 12 min at 550
nm. Vmax was used to calculate the rate, using the extinction coefficient 14.75
mol/cm2, determined as described previously [21]. The rate of superoxide
generation is expressed as nmol 02–/min/ml/10
7 cells and represents super-
oxide generation that is completely inhibited by superoxide dismutase. Super-
oxide generation by neutrophils in the absence of fMLP or PMA triggering was
undetectable. For repletion experiments neutrophils were preincubated with
recombinant murine uPA (1 g/ml, MUPA-903, Molecular Innovations Inc.,
Southfield, MI) for 5 m at 37°C prior to assay.
Determination of degranulation of azurophilic
granules by myeloperoxidase release
Myeloperoxidase release was used as a marker for degranulation of azurophilic
granules. Purified neutrophils were adjusted to 5  106/ml in Dulbecco's
PBS/CaMg (Invitrogen). Cells were pre-incubated with Cytochalasin B (5
g/ml, Sigma) for 3 min at 37°C, followed by the addition of 107 M fMLP
(Calbiochem, La Jolla, CA). For repletion experiments, neutrophils were pre-
incubated with recombinant murine uPA (1 g/ml, MUPA-903, Molecular
Innovations, Inc.) for 5m at 37°C prior to the addition of fMLP. Samples were
removed at various time points, centrifuged at 400 g for 8 min, and the
supernatants removed. Buffer (140 l) was added (88 mM KH2PO4/12.4 mM
K2HPO4/0.5% H2O2/0.17 mg/ml o-dianisidine HCl), and the plate was read
kinetically on a SpectraMax 190 at 490 nm. The rate of myeloperoxidase
(MPO) release is expressed as mOD/min/ml/106 cells. To determine total
cellular MPO content, 2.5  106 cells were lysed in 0.5 ml RIPA lysis buffer
[22] and centrifuged at 14,000 rpm at 4°C. A dose-curve of lysate supernatant
was aliquoted into microplate wells (1–10 l/well) and was analyzed kineti-
cally for MPO activity as described above.
Determination of expression of cell surface
expression of CD11b
Cell surface expression of CD11b was used as a marker for specific granule
degranulation. Purified neutrophils were treated with Cytochalasin B and
fMLP, as above, to induce degranulation. Cells were then centrifuged at 400
rpm for 5 min and resuspended in FA Buffer (Difco Laboratories, Detroit, MI),
which contained 1% FBS/ 0.1% sodium azide at 5  106 cells/ml. Cells were
stained with CD11b-FITC (PharMingen), and mean fluorescence intensity was
determined on a Coulter Elite ESP (Beckman Coulter, Hialeah, FL).
Statistical analysis
Comparisons between group means were performed by paired or unpaired
Students t-tests where appropriate or by ANOVA. Statistical calculations were
done using StatView 5.0 software (Abacus Concepts, Berkeley, CA); n 
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number of mice in each experimental group. Data are expressed  SEM.
Statistical difference was accepted at P  0.05.
RESULTS
Comparison of neutrophil phagoyctosis in WT,
uPA/, and uPAR/ mice
Phagocytosis by peripheral blood neutrophils was compared
by quantifying ingestion of fluorescently labeled E. coli by
fluorescence photomicroscopy and flow cytometry. Fluores-
cence photomicroscopy (Fig. 1) shows the brightly fluores-
cent E. coli within neutrophils obtained from WT, uPA/,
and uPAR/ mice. Nearly all the WT neutrophils in-
gested bacteria. Further, each WT phagocytic neutrophil
ingested several bacteria. By contrast, a very different pat-
tern was seen when phagocytosis by uPA/ and
uPAR/ neutrophils was determined. Fewer of the
uPA/ or uPAR/ neutrophils ingested bacteria. Of
those that were phagocytic, fewer bacteria were ingested per
cell. When subjected to flow cytometry (Fig. 2), the number
of particles ingested and the number of cells that have
ingested bacteria become clearly evident. As shown in Fig.
2A when normalized to WT neutrophils (100 percent), fewer
uPA/ and uPAR/ neutrophils ingested bacteria.
Even more striking is when the mean fluorescence of the cell
populations is assessed (Fig. 2B). This finding reflects the
number of bacteria ingested per cell and evaluates only
those neutrophils that ingested at least one bacteria. The
uPA/ and the uPAR/ neutrophils ingest far fewer
bacteria per cell than do WT neutrophils. This difference
becomes more pronounced when evaluated over time.
Phagocytosis following repletion of uPA/
neutrophils with murine uPA
We next sought to determine whether repletion with recombi-
nant murine uPA would enhance the phagocytosis seen by
uPA/ neutrophils. To accomplish this assessment, neutro-
phils from uPA/ mice were cultured with either the media
from A549 cells transfected with murine uPA or with media
from sham-transfected A549 cells (with the adenovirus vector
containing only an empty cassette). As demonstrated in Fig. 3,
uPA repletion of uPA/ neutrophils enhanced phagocytosis
as shown by the mean fluorescence of phagocytic cells. Thus,
the uPA/ neutrophils demonstrate enhanced phagocytosis
when repleted with murine uPA when compared with uPA/
neutrophils without uPA repletion. Further, the mean log flu-
orescence of the uPA-repleted uPA/ neutrophils ap-
proached that seen in WT neutrophils at 15 m (70.1  23.5 vs.
148.5  0.3, PNS).
Comparison of superoxide production by WT,
uPA/, and uPAR–/– neutrophils
The generation of superoxide is a critical mechanism by which
neutrophils kill bacteria. We therefore evaluated superoxide
production by neutrophils obtained from WT, uPA/, and
uPAR–/– neutrophils. We chose to use fMLP as our stimulus
because it is a potent chemotaxin and activator of neutrophils,
and because it is a bacterial product present in copious
amounts in bacterial culture media. Hence, it is a reasonable
stimulus to assess superoxide generation by neutrophils in the
context of antibacterial defense. As shown in Fig. 4A, both
uPA/ neutrophils and uPAR/ neutrophils generate
substantially less superoxide in response to fMLP than do WT
neutrophils across the entire dose range tested (P0.0005 for
all conditions). In separate experiments (Fig. 4B), we sought to
determine whether the defect in superoxide generation seen in
uPA/ neutrophils could be corrected by the addition of
exogenous recombinant murine uPA. Neutrophils from WT and
uPA/ mice were preincubated in the presence and absence
of recombinant murine uPA for 5 min at 37°C, and then
superoxide generation was assessed as above. As shown in Fig.
4B, uPA-repleted uPA/ neutrophils generated far more
superoxide than did uPA/ neutrophils without repletion
across the entire fMLP dose range (P0.002 for all condi-
tions). Additionally, the superoxide generated by the uPA-
repleted uPA/ neutrophils was no different from the super-
oxide generation seen by WT neutrophils (PNS). These re-
sults demonstrate that the defect in superoxide generation seen
in uPA/ neutrophils can be completely reversed by the
addition of exogenous murine uPA.
To determine whether the mechanism for the reduced levels
of superoxide production seen in the uPA/ or the
uPAR/ neutrophils was due to intracellular defects in
signaling or to plasma membrane events, we determined su-
peroxide generation in response to PMA. PMA directly acti-
vates protein kinase C (PKC), thereby bypassing surface re-
ceptor or more upstream signaling events. When WT,
uPA/, or uPAR/ neutrophils were stimulated with
PMA, superoxide production was equivalent in magnitude
across all groups (Fig. 4C; PNS). We therefore conclude that
the diminished superoxide production by the uPA/ and
uPAR/ neutrophils is the result of cell surface and/or
upstream signaling events and not as a result of an intrinsic
signaling defect at or downstream from PKC.
Fig.1. Comparison of neutrophil phagoyctosis in WT, uPA/, and
uPAR/ mice by fluorescence microscopy. Representative fluroescence
photomicrographs of purified WT, uPA/, and uPAR/ neutrophils after
incubation with fluorescently labeled E. coli for 20 min. The slides were
hematoxylin- and eosin-stained prior to photomicroscopy at 400´ magnification
(n5–8).
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Comparison of the degranulation reponse by WT,
uPA/, and uPAR/ neutrophils
The ability of neutrophils to participate in antibacterial host
defense is in part dependent on several neutrophil-specific
proteins that are contained within discrete intracytoplasmic
granules. Neutrophil activation results in a degranulation re-
sponse that liberates granule contents extracellulary or into
phagolysosomes. To determine the degranulation response in-
volving azurophilic granules, we determined the release of
MPO [23]. Neutrophils from WT, uPA/, and uPAR/
mice were incubated in the presence and absence of 107 M
fMLP. At the end of the incubation period, elaboration of MPO
was determined. As shown in Fig. 5, elaboration of MPO from
unstimulated cells of all genotypes was minimal and equiva-
lent. By contrast, fMLP-stimulated neutrophils from uPA/
mice showed strikingly less elaboration of MPO compared with
neutrophils from WT mice (957.8  64.0 vs. 1620.4  67.7
mOD/min/ml/106 cells, P0.0001). fMLP-stimulated neutro-
phils from uPAR/ mice elaborated equivalent amounts of
MPO compared with fMLP-stimulated neutrophils from WT
mice (PNS). As shown by the lower bars in Fig. 5, repletion
of uPA/ neutrophils with 1 g/ml murine uPA had no
effect on MPO release compared with untreated uPA/
neutrophils at either 0 or 15 min (PNS). Of note, when
equivalent numbers of neutrophils were obtained from WT,
uPA/, and uPAR/ mice and lysed, equivalent amounts
of MPO were found among all the genotypes tested (data not
shown). Therefore, although total cellular MPO content is
consistent among WT, uPA/, and uPAR/ mice, the
uPA/ mice respond with substantially less release of azuro-
philic granules in response to activation compared with WT or
to uPAR/ mice.
The degranulation of neutrophil-specific granules is impor-
tant to antibacterial host defense, in that specific granules
contain lactoferrin, which has bactericidal and bacteriostatic
properties and increases hydroxide ion production when it is
saturated with iron [24]. The 2 integrin CD11b/CD18 is also
contained in specific granules in resting neutrophils and is
translocated to the plasma membrane during degranulation,
which thereby increases the plasma membrane expression
5–10 times the low level of expression seen under resting
conditions. The change in expression of CD11b on the cell
membrane following agonist stimulation is therefore a reliable
marker of exocytois of specific granules [25]. The expression of
cell surface CD11b/CD18 on unstimulated cells was equivalent
comparing the mean log fluorescence of WT to uPA/ or
uPAR/ neutrophils (Table 1, PNS). When stimulated
with fMLP, all three genotypes increased the cell surface
expression of CD11b significantly (P0.05 for all conditions).
Fig. 2. Comparison of neutrophil phagoyctosis in WT, uPA/, and uPAR/ mice by flow cytometry. Purified WT, uPA/, and uPAR/ neutrophils after
incubation with fluorescently labeled E. coli were analyzed by flow cytometry. All values are normalized to the mean of WT neutrophils. (A) Percentage of
neutrophils that have ingested E. coli. (B) Mean fluorescence intensity of neutrophils that have ingested E. coli. WT mice, black bars; uPA/, hatched bars
uPAR/, stippled bars. Data are expressed as mean  SEM; *P  0.05; **P  0.005; ***P  0.0003; n  5–8.
Fig. 3. Effect of repletion of uPA/ neutrophils with murine uPA on
phagocytosis. Phagocytosis of fluorescently labeled E. coli by uPA/ neu-
trophils treated with control media compared with phagocytosis by uPA/
neutrophils treated with murine uPA containing media. Analysis was done by
flow cytometery. All values are the mean fluorescence intensity of neutrophils
that have ingested E. coli normalized to control media-treated uPA/
neutrophils. Neutrophils from uPA/ mice treated with control media,
hatched bars; neutrophils from uPA/ treated with murine uPA containing
media, crosshatched bars. Data are expressed as mean  SEM; **P  0.003;
n  9.
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The degree of increase was the same comparing uPA/ and
uPAR/ neutrophils to WT. Therefore, agonist-stimulated
release of specific granules is not diminished in uPA/ or
uPAR/ mice compared with WT mice.
DISCUSSION
These studies demonstrate the following points: 1) neutrophil
phagocytosis of E. coli is substantially diminished in the ab-
sence of either uPA or uPAR; 2) repletion of uPA/ neu-
trophils with murine uPA substantially reverses the defect in
phagocytosis; 3) generation of superoxide is markedly reduced
in the absence of uPA or uPAR; 4) repletion of uPA/
neutrophils with murine uPA completely reverses the defect in
superoxide generation; 5) neutrophil exocytosis of azurophilic
granules is reduced in the absence of uPA, but not in the
absence of uPAR, and this defect in uPA/ neutrophils is
not corrected by provision of extracellular uPA repletion; and
6) neutrophil exocytosis of specific granules is not reduced by
the absence of either uPA or uPAR. Therefore, we demonstrate
that uPA/uPAR modulates several of the crucial steps in
Fig. 4. Comparison of superoxide production by WT, uPA/, and uPAR–/– neutrophils. (A) fMLP-induced superoxide production by neutrophils. WT mice,
black bars; uPA/ hatched bars, uPAR/ stippled bars. Data are expressed as mean  SEM. *P  0.0005; **P  0.0001; n  5–7. (B) fMLP-induced
superoxide production by neutrophils. WT mice, black bars; uPA/ hatched bars, uPA/  murine crosshatched bars. Data are expressed as mean  SEM.
*P  0.002; **P  0.0003; n  5–7. (C) PMA-induced superoxide production by neutrophils. WT mice, black bars; uPA/, hatched bars; uPAR/, stippled
bars. Data are expressed as mean  SEM. P  NS; n  3–5.
Fig. 5. Determination of myeloperoxidase release as a marker for degranu-
lation of azurophilic granules by WT, uPA/, and uPAR/ neutrophils.
Neutrophils were stimulated with fMLP, and myeloperoxidase release was
determined. WT mice, black bars; uPA/, hatched bars; uPAR/, stip-
pled bars; uPA/  murine uPA, crosshatched bars. Data are expressed as
mean  SEM. *P  0.0001; n  5–9. uPA/ compared with uPA/ 
murine uPA, P  NS for all conditions.
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neutrophil activation that lead to bacterial killing and effective
host defense.
During the process of extravasation from the vascular com-
partment and recruitment to sites of infection, neutrophils
become activated and increase the expression of plasma mem-
brane receptors that mediate phagocytosis, including comple-
ment receptors (CR), especially CR3 (CD11b/CD18), and the
Fc domain of immunoglobulin [24]. CD11b/CD18 is possibly
the most important receptor for neutrophil phagocytosis, as
shown by studies of leukocyte adhesion deficiency (LAD) pa-
tients, who have substantial defects in neutrophil phagocytosis
in addition to defects in adhesion and chemotaxis [26]. We
have previously demonstrated that uPAR facilitates the
CD11b/CD18-dependent functions of chemotaxis and adhesion
and that blockage of uPAR with either antibodies or antisense
oligonucleotides results in near-ablation of chemotaxis and
reduction of adhesion by 	50% [11–13]. The veracity of these
observations has also been demonstrated in vivo, where we,
and others, have shown that uPAR/ mice have defects in
CD11b/CD18 mediated cellular recruitment [14, 27]. The
physical connection between uPAR, the 2 integrins, and the
cytoskeleton has been shown by elegant work demonstrating
that the resistance to movement when magnetic torque is
applied to uPAR-attached beads reflects transmembrane stiff-
ness consistent with an integrin connection to cytoskeletal
components [28]. It is therefore reasonable to propose that
during phagocytosis, uPAR similarly partners with CD11b/
CD18 and thereby enhances its ability to effect phagocytosis of
complement-opsonized bacteria.
In the current study, we provide evidence that the absence
of uPA also greatly reduces neutrophil phagocytosis. This
finding is somewhat unique to phagocytosis among CD11b/
CD18-mediated functions. Anti-sense oligonucleotide block-
ade of uPA has previously been shown to have little effect on
chemotaxis, and to significantly enhance adhesion [11, 13].
Furthermore, neutrophil recruitment to the lungs of uPA/
mice in response to bacterial pneumonia is no different from
recruitment seen in WT mice [14]. This finding suggests that
uPA has little effect on modulating pulmonary recruitment
mediated by the partnership of uPAR with CD11b/CD18.
Rather than modulating partnering of uPAR with 2 integrins,
the role of uPA in neutrophil phagocytosis may be due to its
known ability to transduce signals and induce cellular activa-
tion on binding to uPAR (discussed further below) [29]. Be-
cause uPA is stored in intracellular vesicles in neutrophils and
released into the extracellular compartment during activation,
it is reasonable that the concentration of extracellular uPA, and
therefore uPA-uPAR binding, increases dramatically on neu-
trophil activation [30, 31].
Neutrophil phagocytosis is accompanied by a series of cell
signaling events that trigger oxygen-dependent biochemical
processes that lead to the production and elaboration of reac-
tive oxidants. The microbicidal activity of neutrophils is crit-
ically dependent on the elaboration of these reactive oxidant
species. During phagocytosis, normal leukocytes show an in-
crease in oxygen consumption [32], which is then followed by
the production of superoxide, hydroxyl radical, and hydrogen
peroxide, events known collectively as the respiratory burst
[33]. The respiratory burst is tied to the activation of the
plasma membrane-bound NADPH oxidase, which leads to the
generation of superoxide radicals that, when catalyzed by su-
peroxide dismutase, generates H2O2 and oxygen.
fMLP is commonly used in in vitro systems to mimic the
cellular activation of neutrophils seen in vivo or upon stimu-
lation with bacteria. fMLP binding to neutrophils is a receptor-
mediated event that leads to the activation of guanine nucle-
otide regulatory protein followed by activation of phospholipase
C, which results in IP3 entering the cytosol and the release of
intracellular calcium [34]. PKC is then activated by the PI
breakdown product DAG [35]. The importance of PKC has
been shown using its direct activator, PMA, which is a potent
stimulus for superoxide and H2O2 production [36]. PMA can
therefore allow for the differentiation among cell surface re-
ceptor mediated events and events that occur intracellularly
further down the signal transduction pathway in the generation
of the respiratory burst. Using this approach, we show that
superoxide generation is significantly impaired in response to
fMLP-induced stimulation in uPA/ and uPAR/ neutro-
phils compared with those of WT mice. However, the intracel-
lular machinery of the respiratory burst appears to be fully
intact in uPA/ and uPAR/ mice because the response
to PMA is indistinguishable to that seen in WT. Hence, the
defect in the absence of uPA or uPAR in superoxide generation
lies at, or upstream, of PKC activation and is likely related to
surface receptor-mediated events. The ability to fully correct
the defect in superoxide production seen in uPA/ neutro-
phils with exogenous extracellular uPA, together with the re-
quirement for uPAR expression for superoxide production
comparable with WT neutrophils, provides strong evidence
that the mechanism by which uPA modulates superoxide gen-
eration is through binding to its natural receptor, uPAR, at the
cell surface and thereby initiating signal transduction events.
Although the importance of the respiratory burst in neutro-
phil mediated host defense is indisputable, the specific direct
TABLE 1. Cell Membrane CD11b Expression by Mean Log Fluorescence1
Genotype Unstimulated fMLP-stimulated P 2 P 3 n
WT 110.24  10.184 173.25  23.35 0.05 4
uPA/ 88.17  7.11 137.67  18.0 0.03 NS 6
uPAR/ 77.00  5.12 178.25  36.85 0.04 NS 4
1 Mean log fluorescence channel number  SEM determined by immunofluorescence flow cytometry. 2 Comparing unstimulated to fMLP-stimulated neutrophils
within the same genotype. 3 Comparing uPA/ unstimulated and uPA/ fMLP-stimulated or uPAR/ unstimulated and uPAR/ fMLP-stimulated
neutrophils to WT unstimulated and WT fMLP-stimulated neutrophils, respectively.
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bactericidal role of some of these early oxidants is more con-
troversial. Much of the hydrogen peroxide produced by neu-
trophils is secondarily processed by myeloperoxidase, which
oxidizes chloride ions to HOCl, an extremely potent bacteri-
cidal oxidant [37]. Myeloperoxidase is localized in resting
neutrophils within azurophilic (primary) granules, where it is a
major constituent. As a result of phagocytosis, degranulation
occurs and MPO is discharged extracellularly or into phagoly-
sosomes.
Many species of bacteria require oxidative burst in order for
optimal killing in vivo. A clinical example of this is in chronic
granulomatous disease (CGD), which is a group of syndromes
sharing various defects in components of the NADPH oxidase
complex. Whereas normal leukocytes increase oxygen con-
sumption more than 500% during phagocytosis, CGD neutro-
phils show only a 36% increase [32]. Patients with CDG have
recurrent, severe infections caused by organisms such as
Staphylococci, Aspergillus, Serratia, and Burkholderia cepacia
[38]. Catalase-negative organisms, such as Streptococcus pyo-
genes, Streptococcus pneumoniae, and Haemophilus influenzae,
are not problematic [39, 40]. Patients have also been described
with MPO deficiency. MPO-deficient patients may present with
recurrent fungal and bacterial infections. In vitro experiments
have demonstrated the importance of myeloperoxidase in bac-
terial killing. [37]. Therefore, the diminished superoxide pro-
duction coupled with diminished MPO release seen in the
neutrophils of uPA/ mice provide a mechanism for their
diminished bactericidal activity compared with WT neutro-
phils. Similarly, the diminished superoxide production seen in
the neutrophils of uPAR/ mice would predict diminished
bactericidal activity when compared with WT mice, but
uPAR/ neutrophils should not have a defect in killing to
the extent seen in uPA/ mice, as their ability to elaborate
MPO remains intact.
The degranulation of neutrophil-specific granules is likewise
important in antibacterial host defense. Specific granules con-
tain lactoferrin, which has bacteriocidal and bacteriostatic
properties. Lactoferrin also increases hydroxide ion production
when it is saturated with iron [24]. Degranulation of specific
granules in neutrophils from uPA/ and uPAR/ mice is
indistinguishable from that seen in WT, which suggests that
this limb of antibacterial host defense is fully intact in the
absence of uPA or uPAR. Further, because CD11b/CD18 is a
recognized marker for specific granules, these data also dem-
onstrates that agonist-stimulated expression of CD11b/ CD18
is intact in uPA- and uPAR-deficient animals.
Neutrophil degranulation, rapidly triggered by fMLP, is me-
diated by the activation of src family tyrosine kinases, which
lead to the activation of p38 MAP kinase [41]. Several src-
related tyrosine kinases have been studied in response to fMLP
stimulation, including Lyn [42] and fgr, which is associated
with the secondary granules [43]. Hck, associated with azuro-
philic and secretory granules, translocates to the phagolyso-
some and is activated during phagocytosis [42, 44]. Substantial
evidence links uPA/uPAR to these intracellular signaling path-
ways. uPAR co-precipitates with src type tyrosine kinases. hck
is activated by binding of uPA to uPAR, as is p38, and the
extracellular signal-related kinase 2 (Erk2) [45]. In neutro-
phils, uPA binding to uPAR triggers increases in intracellular
calcium that can be blocked by Ab to either CD11b/ CD18 or
uPAR; transfectant studies have confirmed a requirement for
both CD11b/ CD18 and uPAR. uPA binding to uPAR induces
serine phosphorylation in epithelial cells [46], DAG neosyn-
thesis in epidermal cells [47], activation of the Jak/Stat1 path-
way, and induction of Src-like protein tyrosine kinases (PTK)
in smooth muscle cells [48] and tyrosine phosphorylation in
mononuclear phagocytes [49]. Therefore, it is reasonable to
position uPA-uPAR binding as an important modulator of the
critical pathways of cellular activation required for neutrophil
activation. The current studies provide evidence that uPA
binding to uPAR is the mechanism responsible for the modu-
lation of phagocytosis and superoxide production. This theory
is supported the common defects in uPA/ and uPAR/
mice, which suggest that both uPA and uPAR are necesssary
and that the ability to correct the defects in phagocytosis and
superoxide production in uPA/ neutrophils (which express
uPAR normally) by providing murine uPA extracellularly for a
period of time sufficient for uPAR binding.
However, uPA-mediated signal transduction is complex in
that uPA has also been shown to activate signaling pathways in
an uPAR-independent manner. Recently, the addition of ex-
ogenous human uPA has been shown to potentiate LPS-in-
duced activation of several neutrophil signaling pathways in
murine cells, including Akt and c-Jun N-terminal kinase, and
the expression of pro-inflammatory cytokines [50]. Because
human uPA cannot bind to murine uPAR [51], the potentiation
of these critical pathways is induced by uPA by a mechanism
that is independent of uPAR. uPA induces tyrosine phosphor-
ylation of 78 kDa in a human epithelial cell line in a proteol-
ysis-dependent, but uPAR-independent, mechanism [52]. A
mechanism by which uPA may transduce uPAR-independent
signals is by associating with other cell surface receptors, most
notably by binding directly to CD11b/CD18 [53]. Alternatively,
uPA, through its proteolytic functions, may signal indirectly
through intermediate proteases, including plasmin [54–56]. In
our experiements investigating release of azurophilic granules,
the role of uPA is clearly independent of uPAR binding, as
uPAR/ and WT neutrophils release MPO comparably.
Further, the defect seen in uPA/ cells cannot be corrected
by providing extracellular murine uPA for a time period suf-
ficient for uPAR binding.
In summary, we have demonstrated that expression of uPA
and uPAR is required for normal neutrophil phagocytosis of
bacteria and fMLP-stimulated superoxide generation. The ab-
sence of either uPA or uPAR results in profound impairment of
these two critical mechanisms of neutrophil-mediated host
defense. We also show that degranulation of azurophilic gran-
ules is impaired in the absence of uPA, but not in the absence
of uPAR. Thus, the uPA/ uPAR system is critically involved in
several aspects of host inflammatory responses, including cel-
lular recruitment, phagocytosis and regulation of leukocyte
antimicrobial activation.
ACKNOWLEDGMENTS
The authors would like to thank Peter Carmeliet for generously
providing the uPA/, uPAR/ and background matched
654 Journal of Leukocyte Biology Volume 76, September 2004 http://www.jleukbio.org
WT mice. This work was supported by a Merit Research Grant
and Research Enhancement Award Program funds (REAP)
from the Department of Veterans Affairs (M.R.G.) and by
National Institutes of Health grant HL60620 (M.R.G.).
REFERENCES
1. Wilkinson, P., Haston, W. (1988) Chemotaxis: An overview. Methods
Enzymol. 162, 3–16.
2. Lauffenburger, D. (1991) Models for receptor-mediated cell phenomena:
Adhesion and migration. Annu. Rev. Biophys. Biophys. Chem. 20, 387–
414.
3. Danø, K., Andreasen, P., Grondahl-Hansen, J., Kristensen, P., Nielsen, L.,
Skriver, L. (1985) Plaminogen activators, tissue degradation, and cancer.
Adv. Cancer Res. 44, 139–265.
4. Huber, A. R., Ellis, S., Johnson, K. J., Dixit, V. M., Varani, J. (1992)
Monocyte diapedesis through an in vitro vessel wall construct: Inhibition
with monoclonal antibodies to thrombospondin. J. Leukoc. Biol. 52,
524–528.
5. Kirchmeimer, J. C., Wojta, J., Christ, G., Hienert, G., Binder, B. R. (1988)
Mitogenic effect of urokinase on malignant and unaffected adjacent human
renal cells. Carcinogenesis 9, 2121–2123.
6. Liotta, L. A., Goldfarb, R. H., Brundange, R., Siegal, G. P., Terranova, V.,
Garbisa, S. (1981) Effect of plasminogen activator (urokinase), plasmin,
and thrombin on glycoprotein and collagenous components of basement
membrane. Cancer Res. 41, 4629–4636.
7. Vassalli, J., Sappino, A., Belin, D. (1991) The plasminogen activator/
plasmin system. J. Clin. Invest. 88, 1067–1072.
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